Cargando…
An Experimental Study: Benefits of Digoxin on Hepatotoxicity Induced by Methotrexate Treatment
PURPOSE: The aim of the study is to examine the possible therapeutic effects of a known cardiac glycoside, digoxin, on a rat model of MTX-induced hepatotoxicity. METHODS: The study was conducted on twenty-four male rats. While eighteen rats received a single dose of 20 mg/kg MTX to obtain an injured...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598353/ https://www.ncbi.nlm.nih.gov/pubmed/34804155 http://dx.doi.org/10.1155/2021/6619844 |
_version_ | 1784600807724810240 |
---|---|
author | Taskin, Banu Erdoğan, Mümin Alper Yiğittürk, Gürkan Alper, Sibel Erbaş, Oytun |
author_facet | Taskin, Banu Erdoğan, Mümin Alper Yiğittürk, Gürkan Alper, Sibel Erbaş, Oytun |
author_sort | Taskin, Banu |
collection | PubMed |
description | PURPOSE: The aim of the study is to examine the possible therapeutic effects of a known cardiac glycoside, digoxin, on a rat model of MTX-induced hepatotoxicity. METHODS: The study was conducted on twenty-four male rats. While eighteen rats received a single dose of 20 mg/kg MTX to obtain an injured liver model, six rats constituted the control group. Also, the eighteen liver toxicity model created rats were equally divided into two groups, one of which received digoxin 0.1 mg/kg/day digoxin (Group 1) and the other group (Group 2) was given saline (% 0.9NaCl) with a dose of 1 ml/kg/day for ten days. Following the trial, the rats were sacrificed to harvest blood and liver tissue samples to determine blood and tissue MDA, serum ALT, plasma TNF-α, TGF-β, IL-6, IL-1-Beta, and PTX3 levels. RESULTS: MTX's structural and functional hepatotoxicity was observable and evidenced by relatively worse histopathological scores and increased biochemical marker levels. Digoxin treatment significantly reduced the liver enzyme ALT, plasma TNF-α, TGF-β, PTX3, and MDA levels and decreased histological changes in the liver tissue with MTX-induced hepatotoxicity in the rat model. CONCLUSION: We suggest that digoxin has an anti-inflammatory and antihepatotoxic effect on the MTX-induced liver injury model. |
format | Online Article Text |
id | pubmed-8598353 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-85983532021-11-18 An Experimental Study: Benefits of Digoxin on Hepatotoxicity Induced by Methotrexate Treatment Taskin, Banu Erdoğan, Mümin Alper Yiğittürk, Gürkan Alper, Sibel Erbaş, Oytun Gastroenterol Res Pract Research Article PURPOSE: The aim of the study is to examine the possible therapeutic effects of a known cardiac glycoside, digoxin, on a rat model of MTX-induced hepatotoxicity. METHODS: The study was conducted on twenty-four male rats. While eighteen rats received a single dose of 20 mg/kg MTX to obtain an injured liver model, six rats constituted the control group. Also, the eighteen liver toxicity model created rats were equally divided into two groups, one of which received digoxin 0.1 mg/kg/day digoxin (Group 1) and the other group (Group 2) was given saline (% 0.9NaCl) with a dose of 1 ml/kg/day for ten days. Following the trial, the rats were sacrificed to harvest blood and liver tissue samples to determine blood and tissue MDA, serum ALT, plasma TNF-α, TGF-β, IL-6, IL-1-Beta, and PTX3 levels. RESULTS: MTX's structural and functional hepatotoxicity was observable and evidenced by relatively worse histopathological scores and increased biochemical marker levels. Digoxin treatment significantly reduced the liver enzyme ALT, plasma TNF-α, TGF-β, PTX3, and MDA levels and decreased histological changes in the liver tissue with MTX-induced hepatotoxicity in the rat model. CONCLUSION: We suggest that digoxin has an anti-inflammatory and antihepatotoxic effect on the MTX-induced liver injury model. Hindawi 2021-11-10 /pmc/articles/PMC8598353/ /pubmed/34804155 http://dx.doi.org/10.1155/2021/6619844 Text en Copyright © 2021 Banu Taskin et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Taskin, Banu Erdoğan, Mümin Alper Yiğittürk, Gürkan Alper, Sibel Erbaş, Oytun An Experimental Study: Benefits of Digoxin on Hepatotoxicity Induced by Methotrexate Treatment |
title | An Experimental Study: Benefits of Digoxin on Hepatotoxicity Induced by Methotrexate Treatment |
title_full | An Experimental Study: Benefits of Digoxin on Hepatotoxicity Induced by Methotrexate Treatment |
title_fullStr | An Experimental Study: Benefits of Digoxin on Hepatotoxicity Induced by Methotrexate Treatment |
title_full_unstemmed | An Experimental Study: Benefits of Digoxin on Hepatotoxicity Induced by Methotrexate Treatment |
title_short | An Experimental Study: Benefits of Digoxin on Hepatotoxicity Induced by Methotrexate Treatment |
title_sort | experimental study: benefits of digoxin on hepatotoxicity induced by methotrexate treatment |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598353/ https://www.ncbi.nlm.nih.gov/pubmed/34804155 http://dx.doi.org/10.1155/2021/6619844 |
work_keys_str_mv | AT taskinbanu anexperimentalstudybenefitsofdigoxinonhepatotoxicityinducedbymethotrexatetreatment AT erdoganmuminalper anexperimentalstudybenefitsofdigoxinonhepatotoxicityinducedbymethotrexatetreatment AT yigitturkgurkan anexperimentalstudybenefitsofdigoxinonhepatotoxicityinducedbymethotrexatetreatment AT alpersibel anexperimentalstudybenefitsofdigoxinonhepatotoxicityinducedbymethotrexatetreatment AT erbasoytun anexperimentalstudybenefitsofdigoxinonhepatotoxicityinducedbymethotrexatetreatment AT taskinbanu experimentalstudybenefitsofdigoxinonhepatotoxicityinducedbymethotrexatetreatment AT erdoganmuminalper experimentalstudybenefitsofdigoxinonhepatotoxicityinducedbymethotrexatetreatment AT yigitturkgurkan experimentalstudybenefitsofdigoxinonhepatotoxicityinducedbymethotrexatetreatment AT alpersibel experimentalstudybenefitsofdigoxinonhepatotoxicityinducedbymethotrexatetreatment AT erbasoytun experimentalstudybenefitsofdigoxinonhepatotoxicityinducedbymethotrexatetreatment |